Related references
Note: Only part of the references are listed.Azathioprine Is Effective in Corticosteroid-dependent Asian Inflammatory Bowel Disease Patients
Kelvin T. Thia et al.
INFLAMMATORY BOWEL DISEASES (2011)
EFFICACY OF AZATHIOPRINE IN MILD OR MODERATE RELAPSE IN CROHN'S DISEASE: CLINICAL AND ENDOSCOPIC EVALUATION
Yuji Murakami et al.
DIGESTIVE ENDOSCOPY (2010)
Inflammatory Bowel Disease in Korea: Epidemiological, Genomic, Clinical, and Therapeutic Characteristics
Eun Soo Kim et al.
GUT AND LIVER (2010)
Correlation of genotypes for thiopurine methyltransferase and inosine triphosphate pyrophosphatase with long-term clinical outcomes in Korean patients with inflammatory bowel diseases during treatment with thiopurine drugs
Yoon Suk Jung et al.
JOURNAL OF HUMAN GENETICS (2010)
Infliximab, Azathioprine, or Combination Therapy for Crohn's Disease.
Jean Frederic Colombel et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Thiopurine therapy in inflammatory bowel disease
Christina Ha et al.
EXPERT REVIEW OF GASTROENTEROLOGY & HEPATOLOGY (2010)
Azathioprine and 6-Mercaptopurine for the Prevention of Postoperative Recurrence in Crohn's Disease: A Meta-Analysis
Laurent Peyrin-Biroulet et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2009)
Evolving Inflammatory Bowel Disease Treatment Paradigms: Top-Down Versus Step-Up
Shane M. Devlin et al.
GASTROENTEROLOGY CLINICS OF NORTH AMERICA (2009)
Patients' Attitudes to Medicines and Adherence to Maintenance Treatment in Inflammatory Bowel Disease
Rob Horne et al.
INFLAMMATORY BOWEL DISEASES (2009)
Mucosal Healing Predicts Long-term Outcome of Maintenance Therapy with Infliximab in Crohn's Disease
Fabian Schnitzler et al.
INFLAMMATORY BOWEL DISEASES (2009)
An Update on the Epidemiology of Inflammatory Bowel Disease in Asia
Kelvin T. Thia et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2008)
Should azathioprine and 5-aminosalicylates be coprescribed in inflammatory bowel disease?: an audit of adverse events and outcome
Jayshri A. Shah et al.
EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY (2008)
Predicting relapse in Crohn's disease: a biopsychosocial model
A. Bitton et al.
GUT (2008)
Epidemiology of inflammatory bowel disease in the Songpa-Kangdong district, Seoul, Korea, 1986-2005: A KASID study
Suk-Kyun Yang et al.
INFLAMMATORY BOWEL DISEASES (2008)
Monitoring 6-thioguanine nucleotide concentrations in Japanese patients with inflammatory bowel disease
Akira Andoh et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2008)
Risk factors for non-adherence to medication in inflammatory bowel disease patients
R. D'Inca et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2008)
Long-term outcome of Crohn's disease following corticosteroid-induced remission
Claudio Papi et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2007)
Review article: biological activity markers in inflammatory bowel disease
D. Desai et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2007)
Thiopurine methyltransferase (TPMT) activity and adverse effects of azathioprine in inflammatory bowel disease:: Long-term follow-up study of 394 patients
Javier P. Gisbert et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2006)
Pharmacogenetics during standardised initiation of thiopurine treatment in inflammatory bowel disease
U. Hindorf et al.
GUT (2006)
A simple biological score for predicting low risk of short-term relapse in Crohn's disease
Yann Consigny et al.
INFLAMMATORY BOWEL DISEASES (2006)
5-Aminosalicylate therapy is associated with higher 6-thioguanine levels in adults and children with inflammatory bowel disease in remission on 6-mercaptopurine or azathioprine
S Hande et al.
INFLAMMATORY BOWEL DISEASES (2006)
Inosine triphosphate pyrophosphatase and thiopurine S-methyltransferase genotypes relationship to azathioprine-induced myelosuppression
Z Zelinkova et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2006)
The pharmacokinetic effect of discontinuation of mesalazine on mercaptopurine metabolite levels in inflammatory bowel disease patients
LPL Gilissen et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2005)
Correlation of C-reactive protein with clinical, endoscopic, histologic, and radiographic activity in inflammatory bowel disease
CA Solem et al.
INFLAMMATORY BOWEL DISEASES (2005)
Immunity, inflammation, and allergy in the gut
TT MacDonald et al.
SCIENCE (2005)
C-reactive protein as a marker for inflammatory bowel disease
S Vermeire et al.
INFLAMMATORY BOWEL DISEASES (2004)
The immunological and genetic basis of inflammatory bowel disease
G Bouma et al.
NATURE REVIEWS IMMUNOLOGY (2003)
Low-dose azathioprine is effective and safe for maintenance of remission in patients with ulcerative colitis
T Hibi et al.
JOURNAL OF GASTROENTEROLOGY (2003)
Long-term evolution of disease behavior of Crohn's disease
J Cosnes et al.
INFLAMMATORY BOWEL DISEASES (2002)
The efficacy of azathioprine for the treatment of inflammatory bowel disease: a 30 year review
AG Fraser et al.
GUT (2002)
A review of activity indices and efficacy Endpoints for clinical trials of medical therapy in adults with Crohn's disease
WJ Sandborn et al.
GASTROENTEROLOGY (2002)
Epidemiology of inflammatory bowel disease
EV Loftus et al.
GASTROENTEROLOGY CLINICS OF NORTH AMERICA (2002)
Leucopenia resulting from a drug interaction between azathioprine or 6-mercaptopurine and mesalamine, sulphasalazine, or balsalazide
PW Lowry et al.
GUT (2001)
Share Paper
